|1.||Neubauer, Aljoscha S: 2 articles (09/2006 - 07/2005)|
|2.||Kampik, Anselm: 2 articles (09/2006 - 07/2005)|
|3.||Alge, Claudia S: 2 articles (09/2006 - 07/2005)|
|4.||Priglinger, Siegfried G: 2 articles (09/2006 - 07/2005)|
|5.||Griffin, Martin: 2 articles (06/2004 - 08/2003)|
|6.||Johnson, Timothy S: 2 articles (06/2004 - 08/2003)|
|7.||El Nahas, A Meguid: 2 articles (06/2004 - 08/2003)|
|8.||El Nahas, A M: 2 articles (01/2004 - 05/2001)|
|9.||Skill, N J: 2 articles (01/2004 - 05/2001)|
|10.||Johnson, T S: 2 articles (01/2004 - 05/2001)|
05/01/2001 - "Determination of CSF N(epsilon)(gamma-glutamyl)lysine isodipeptide concentration offers a novel method for measurement of neurodegeneration in primary and mixed dementias."
05/01/2001 - "The concentration of N(epsilon)(gamma-glutamyl)lysine was measured in the cerebrospinal fluid (CSF) of patients with probable Alzheimer's disease (n = 14) and vascular type dementia (n = 11) and compared with not demented surgical controls (n = 17). "
02/18/2003 - "Immunohistochemical studies on postmortem brain tissue confirmed the presence of transglutaminase-catalyzed epsilon (gamma-glutamyl)lysine cross-links in the halo of Lewy bodies in Parkinson's disease and dementia with Lewy bodies, colocalizing with alpha-synuclein. "
|2.||Parkinson Disease (Parkinson's Disease)
07/01/2005 - "Immunohistochemistry demonstrated a distinct staining for tTG, kTG, and epsilon-(gamma-glutamyl)-lysine in the corneal scar. "
01/01/2004 - "tTg staining correlated with epsilon-(gamma-glutamyl)lysine (r = 0.615, p < 0.01) and renal scarring (Masson's trichrome, r = 0.728, p < 0.001). "
01/01/2004 - "In non-diabetic kidney scarring the protein crosslinking enzyme tissue transglutaminase (tTg) has been implicated in this process by the formation of increased epsilon-(gamma-glutamyl)lysine bonds between ECM components in both experimental and human disease. "
08/01/2003 - "Changes in renal tTg and its product, the epsilon(gamma-glutamyl) lysine crosslink, occur in progressive renal scarring in humans independently of the original etiology and in a similar manner to experimental models. "
05/01/2001 - "In experimental renal scarring, the protein cross-linking enzyme, tissue transglutaminase (tTg), is up-regulated and externalized causing an increase in its crosslink product, epsilon-(gamma-glutamyl)-lysine, in the extracellular space. "
07/01/2009 - "The results suggest that epsilon(gamma-glutamyl) lysine cross-linking is not directly related to the progression of renal fibrosis in ICGN mice."
06/15/2004 - "The eight patients who developed CAN had further increases in immunostainable tTg (+197.2%, P <0.001) and epsilon-(gamma-glutamyl) lysine bonds (+465%, P <0.01) that correlated with interstitial fibrosis (r=0.843, P =0.009 and r=0.622, P =0.05, respectively). "
06/15/1997 - "Levels of epsilon-(gamma-glutamyl) lysine cross-link correlated well with the renal fibrosis score throughout the 120 observation days (r = 0.78, P </= 0.01). "
10/01/1999 - "It was recently demonstrated that renal tissue transglutaminase (tTg) protein and its catalytic product the epsilon(gamma-glutamyl) lysine protein cross-link are significantly increased in the subtotal (5/6) nephrectomy model (SNx) of renal fibrosis in rats. "
06/15/1997 - "This observed association between tissue transglutaminase, epsilon-(gamma-glutamyl) lysine cross-link, and renal tubulointerstitial scarring in rats submitted to SNx suggests that tissue transglutaminase may play an important role in the development of experimental renal fibrosis and the associated loss of tubule integrity."
|3.||tau Proteins (tau Protein)
|8.||Transforming Growth Factor beta1 (TGF beta 1)
|10.||Messenger RNA (mRNA)
|1.||Laser In Situ Keratomileusis (LASIK)
|2.||Homologous Transplantation (Allograft)